Senseera: Valuation, Funding & Investors
Senseera is a liquid biopsy company specializing in chromatin epigenomics. Their GEM BIOMARKERS™ platform, utilizing cfChIP-seq technology, enables the decoding of cell-specific gene expression and cell states from a simple blood draw. This innovative approach provides detailed molecular insights for diagnosing and monitoring diseases, offering the precision of biopsy-level insights with the convenience of a non-invasive test.
Leadership & Board
- Current Number of Employees
- 18
- Current LinkedIn Followers
- 1,645
Latest Estimated Valuation
- Total Amount Raised
- $7M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $7M
- Latest Funding Round
- Seed Round
Employee Trend
Senseera had 18 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Senseera had 1,645 followers as of November 16, 2026. The number of followers increased by 3 (0.18%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 07, 2025 | Seed Round | $7.10M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Lightspeed Venture Partners | Seed Round |
| I-Next Capital | Seed Round |
| Lowy Medical Research Institute | Seed Round |
Similar Companies
A snapshot of private companies similar to Senseera, helping you discover and navigate related company profiles.
Related News and Analysis








